131 related articles for article (PubMed ID: 19321041)
1. The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator.
Castellani ML; Kempuraj D; Salini V; Vecchiet J; Tete S; Ciampoli C; Conti F; Cerulli G; Caraffa A; Antinolfi P; Theoharides TC; De Amicis D; Perrella A; Cuccurullo C; Boscolo P; Shaik Y
J Biol Regul Homeost Agents; 2009; 23(1):11-4. PubMed ID: 19321041
[TBL] [Abstract][Full Text] [Related]
2. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).
Conti P; Youinou P; Theoharides TC
Autoimmun Rev; 2007 Jan; 6(3):131-7. PubMed ID: 17289547
[TBL] [Abstract][Full Text] [Related]
3. Disease-associated functions of IL-33: the new kid in the IL-1 family.
Liew FY; Pitman NI; McInnes IB
Nat Rev Immunol; 2010 Feb; 10(2):103-10. PubMed ID: 20081870
[TBL] [Abstract][Full Text] [Related]
4. [Role of interleukin-9 in asthma and allergic reactions].
Renauld JC
Bull Mem Acad R Med Belg; 2007; 162(5-6):275-82; discussion 283-5. PubMed ID: 18404997
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 family cytokines and mast cells: activation and inhibition.
Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
[TBL] [Abstract][Full Text] [Related]
6. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Monteleone G; Pallone F; Macdonald TT
Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
[TBL] [Abstract][Full Text] [Related]
8. Impact of IL -9 and IL-33 in mast cells.
Sabatino G; Nicoletti M; Neri G; Saggini A; Rosati M; Conti F; Cianchetti E; Toniato E; Fulcheri M; Caraffa A; Antinolfi P; Frydas S; Pandolfi F; Potalivo G; Galzio R; Conti P; Theoharides TC
J Biol Regul Homeost Agents; 2012; 26(4):577-86. PubMed ID: 23241108
[TBL] [Abstract][Full Text] [Related]
9. IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells.
Conti P; Ronconi G; Caraffa A; Lessiani G; Duraisamy K
Immunol Invest; 2017 Apr; 46(3):239-250. PubMed ID: 27982737
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease.
Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E
Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.
Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T
Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862
[TBL] [Abstract][Full Text] [Related]
12. The biological paths of IL-1 family members IL-18 and IL-33.
Smith DE
J Leukoc Biol; 2011 Mar; 89(3):383-92. PubMed ID: 20952658
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
[TBL] [Abstract][Full Text] [Related]
14. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor.
Dinarello CA
Immunity; 2005 Nov; 23(5):461-2. PubMed ID: 16286013
[TBL] [Abstract][Full Text] [Related]
15. IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production.
Schneider E; Petit-Bertron AF; Bricard R; Levasseur M; Ramadan A; Girard JP; Herbelin A; Dy M
J Immunol; 2009 Sep; 183(6):3591-7. PubMed ID: 19684081
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 21 as a target of intervention in autoimmune disease.
Ettinger R; Kuchen S; Lipsky PE
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821
[TBL] [Abstract][Full Text] [Related]
17. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
van Es T; van Puijvelde GH; Ramos OH; Segers FM; Joosten LA; van den Berg WB; Michon IM; de Vos P; van Berkel TJ; Kuiper J
Biochem Biophys Res Commun; 2009 Oct; 388(2):261-5. PubMed ID: 19660432
[TBL] [Abstract][Full Text] [Related]
18. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
19. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
[TBL] [Abstract][Full Text] [Related]
20. [Cytokines and asthma].
Rekik WK; Ayoub A
Tunis Med; 1998 Feb; 76(2):1027-32. PubMed ID: 9844537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
